Related Experiment Video

Updated: May 13, 2026

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia
09:46

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

Published on: February 16, 2024

Recent advances in the management of choreas

Jean-Marc Burgunder1

  • 1Swiss Huntington's Disease Centre, Department of Neurology, University of Bern, Neurobu Clinics, Steinerstrasse 45, CH 3006 Bern, Switzerland.

Therapeutic Advances in Neurological Disorders
|March 14, 2013
PubMed

Insights

Managing chorea, especially Huntington's disease, requires comprehensive diagnosis and tailored therapies. This review emphasizes genetic counseling, precise observation, and multidisciplinary care for effective patient management.

Area of Science:

  • Neurology
  • Genetics
  • Pharmacology

Background:

  • Chorea management, particularly for Huntington's disease, is complex and requires diverse expertise.
  • Recent publications highlight advancements in understanding and managing this neurological disorder.

Purpose of the Study:

  • To review current knowledge on chorea management, focusing on Huntington's disease.
  • To integrate new findings with established diagnostic and therapeutic procedures.

Main Methods:

  • Review of recent literature on Huntington's disease management.
  • Emphasis on diagnostic approaches, including differential diagnosis and genetic testing.
  • Discussion of pharmacological and non-pharmacological treatment strategies.

Main Results:

  • Accurate diagnosis and differential diagnosis are crucial for identifying treatable causes of chorea.
  • Genetic testing and counseling are important components of patient management.
  • Pharmacological treatments, though evidence-limited, focus on motor and psychiatric symptoms.
  • Non-pharmacological interventions are vital and best delivered in a multidisciplinary setting.

Conclusions:

  • Effective Huntington's disease management necessitates a holistic approach.
  • Integrating genetic insights with clinical observation guides tailored therapeutic interventions.
  • Multidisciplinary care is essential for addressing the complex needs of patients with chorea.

Keywords:
ChoreaHuntington’s diseasediagnosismanagementtreatment

More Related Videos

Robotic Myotomy and Partial Fundoplication for Achalasia11:19

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Movement Retraining using Real-time Feedback of Performance08:16

Movement Retraining using Real-time Feedback of Performance

Published on: January 17, 2013

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...